Category: Inside BIO Industry Analysis
Ten Years of Therapeutic Venture Capital
What therapeutic areas have received the most funding in private drug companies over the last …
Forbes Asks: Should Economists Perform Surgery and Doctors Conduct Economic Policy?
Over at Forbes, University of Chicago economist Tomas Philipson has an insightful post analyzing several …
Announcing the BIO/Bloomberg Intelligence: 2015 Biotech Industry Outlook Survey
Click here for the BIO/Bloomberg Intelligence: 2015 Biotech Industry Outlook Survey. Your investment plans and …
Exclusive FDA Survey Webinar
BIO is conducting an exciting new survey designed to measure FDA/Sponsor Interactions During Drug Development. …
The Eyes Have It According to Recent VC Funding Patterns
A recent Wall Street Journal analysis of venture capital investment trends since 1999 reveals which …
Back to School: Consider a STEM Career
With school resuming for many throughout the country this week, one question that may be …
Goodbye, For Now, to our Summer Intern
Summer is winding down. Over the next few weeks, student will be returning to America’s …
Biotech Stocks: Perspective in a Bull Market
Investors are increasingly interested in biotechnology based on scientific breakthroughs, an improved regulatory environment, strong …
Biobased Companies Take A Closer Look At Sustainability
BIO and its member companies are constantly working together to help shift the world’s reliance …
Will We Ever Have Genetically Modified Meat?
Currently, there are no genetically engineered animals sold for human consumption on the market, reports …